• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Ypsomed, S3 Connected Health partner to expand digital offerings

June 22, 2023 By Sean Whooley

Ypsomed S3 Connected Health digital health partnership
[Image courtesy of Ypsomed and S3 Connected Health]
Ypsomed announced plans to expand its offerings of digital health solutions for chronic disease therapy together with S3 Connected Health.

Dublin, Ireland-based S3 Connected Health specializes as a digital health partner for life science companies. This partnership allows Ypsomed’s biopharma customers to quickly launch therapy-specific digital patient solutions. It enables therapy management support for acute and chronic diseases while enhancing outcomes.

Ypsomed said in a news release that the companies aim to create an extendable platform to create specific solutions. These offerings provide patients with support and guidance throughout therapy. Ypsomed’s connected injection devices, including the SmartPilot for YpsoMate, come pre-integrated into the platform.

The platform itself offers versatility and customization capabilities for any disease area and use case, the companies say.

“The new platform will enable our Pharma and Biotech customers to rapidly launch integrated device and digital health solutions that will further improve therapy outcomes and quality of life for their patients,” said Ulrike Bauer, Ypsomed chief business officer for delivery systems. “This new product offering complements our existing product portfolio and partnerships in the connected device and digital health area. It will help us to strengthen our position in this space and provide our customers with the best possible value.”

How Ypsomed and S3 Connected Health plan to combine offerings

S3 Connected Health’s Affinial platform powers the offering, encoding more than 20 years of best practice experience into digital health delivery.

The new platform from the companies includes a patient application, a clinical system and a patient support portal. Its analytical dashboard features real-time access to anonymized data.

With pre-integration into Ypsomed’s device portfolio, the platform offers a range of features around self-injection. It also incorporates behavioral science mechanisms to ensure high levels of engagement, plus personalization to patient needs.

“We look forward to collaborating closely with Ypsomed to achieve our shared vision of improving patients’ lives. Our Affinial platform and deep expertise in creating and operating regulated digital health solutions is a perfect fit with Ypsomed’s drive for innovation and highest quality,” said Jim O’Donoghue, President of S3 Connected Health.

The new product offering will be marketed through Ypsomed and will be offered to customers in collaboration with S3 Connected Health for customization to serve their specific use cases and brand.

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Technology Tagged With: S3 Connected Health, Ypsomed

IN CASE YOU MISSED IT

  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS